Skip to main content
. 2023 Jun 7;93:104644. doi: 10.1016/j.ebiom.2023.104644

Fig. 5.

Fig. 5

Graphical summary of the prognostic and predictive relevance of eTILs in cutaneous melanoma. eTILs could be used as a prognostic biomarker in primary melanoma that complements staging and as a predictive biomarker in melanoma metastases for anti-PD-1-based immunotherapy.